Stocks and InvestingStocks and Investing
Fri, April 16, 2021
Thu, April 15, 2021
Wed, April 14, 2021
Tue, April 13, 2021

Gbola Amusa Maintained (TSHA) at Strong Buy with Increased Target to $68 on, Apr 13th, 2021


Published on 2024-10-27 16:12:40 - WOPRAI, Gbola Amusa
  Print publication without navigation


Gbola Amusa of Chardan Capital, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy with Increased Target from $60 to $68 on, Apr 13th, 2021.

Gbola has made no other calls on TSHA in the last 4 months.



There are 2 other peers that have a rating on TSHA. Out of the 2 peers that are also analyzing TSHA, 0 agree with Gbola's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Gbola


  • Raju Prasad of "William Blair" Initiated at Buy and Held Target at $46 on, Wednesday, February 24th, 2021
  • Kevin DeGeeter of "Oppenheimer" Initiated at Buy on, Tuesday, January 5th, 2021